Anastassia Todor

1.0k total citations
18 papers, 822 citations indexed

About

Anastassia Todor is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Anastassia Todor has authored 18 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Anastassia Todor's work include Cardiac Ischemia and Reperfusion (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Mitochondrial Function and Pathology (3 papers). Anastassia Todor is often cited by papers focused on Cardiac Ischemia and Reperfusion (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Mitochondrial Function and Pathology (3 papers). Anastassia Todor collaborates with scholars based in United States and Netherlands. Anastassia Todor's co-authors include Hani N. Sabbah, Victor G. Sharov, George Suzuki, Sidney Goldstein, Norman A. Silverman, Elaine J. Tanhehco, Sidney Goldstein, Takayuki Mishima, Makoto Imai and Hideaki Morita and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Anastassia Todor

18 papers receiving 801 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anastassia Todor 496 328 198 135 105 18 822
Elza D. van Deel 415 0.8× 358 1.1× 130 0.7× 87 0.6× 96 0.9× 26 933
Pericle Di Napoli 411 0.8× 201 0.6× 205 1.0× 150 1.1× 58 0.6× 28 882
Zhenhong Fu 210 0.4× 323 1.0× 134 0.7× 90 0.7× 81 0.8× 30 850
Youchun Jiang 328 0.7× 371 1.1× 120 0.6× 119 0.9× 104 1.0× 10 942
Janice M. Pfeffer 636 1.3× 192 0.6× 104 0.5× 85 0.6× 49 0.5× 32 785
Suneet Purohit 288 0.6× 412 1.3× 158 0.8× 55 0.4× 50 0.5× 5 753
Omar Nass 680 1.4× 250 0.8× 75 0.4× 65 0.5× 177 1.7× 10 796
Eduardo M. Escudero 354 0.7× 240 0.7× 65 0.3× 76 0.6× 45 0.4× 20 583
Makoto Ariyoshi 317 0.6× 656 2.0× 209 1.1× 108 0.8× 82 0.8× 21 1.3k
Quan He 361 0.7× 653 2.0× 122 0.6× 86 0.6× 54 0.5× 38 1.1k

Countries citing papers authored by Anastassia Todor

Since Specialization
Citations

This map shows the geographic impact of Anastassia Todor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastassia Todor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastassia Todor more than expected).

Fields of papers citing papers by Anastassia Todor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anastassia Todor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastassia Todor. The network helps show where Anastassia Todor may publish in the future.

Co-authorship network of co-authors of Anastassia Todor

This figure shows the co-authorship network connecting the top 25 collaborators of Anastassia Todor. A scholar is included among the top collaborators of Anastassia Todor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastassia Todor. Anastassia Todor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sharov, Victor G., Anastassia Todor, Sanjaya Khanal, Makoto Imai, & Hani N. Sabbah. (2006). Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure. Journal of Molecular and Cellular Cardiology. 42(1). 150–158. 85 indexed citations
2.
Morita, Hideaki, Sanjaya Khanal, Sharad Rastogi, et al.. (2006). Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 290(6). H2522–H2527. 33 indexed citations
3.
Sharov, Victor G., Sawa Kostin, Anastassia Todor, Jutta Schaper, & Hani N. Sabbah. (2005). Expression of Cytoskeletal, Linkage and Extracellular Proteins in Failing Dog Myocardium. Heart Failure Reviews. 10(4). 297–303. 23 indexed citations
4.
Sharov, Victor G., Anastassia Todor, & Hani N. Sabbah. (2005). Left Ventricular Histomorphometric Findings in Dogs with Heart Failure Treated with the Acorn Cardiac Support Device. Heart Failure Reviews. 10(2). 141–147. 8 indexed citations
5.
Sharov, Victor G., Anastassia Todor, Makoto Imai, & Hani N. Sabbah. (2005). Inhibition of Mitochondrial Permeability Transition Pores by Cyclosporine A Improves Cytochrome c Oxidase Function and Increases Rate of ATP Synthesis in Failing Cardiomyocytes. Heart Failure Reviews. 10(4). 305–310. 39 indexed citations
6.
Sabbah, Hani N., Hideaki Morita, George Suzuki, et al.. (2004). 1116-12 PG-530742, a novel matrix metalloproteinase inhibitor, improves left ventricular function and attenuates remodeling in dogs with chronic heart failure. Journal of the American College of Cardiology. 43(5). A22–A22. 1 indexed citations
7.
Suzuki, George, Takayuki Mishima, Elaine J. Tanhehco, et al.. (2003). Effects of the AT1‐receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure. British Journal of Pharmacology. 138(2). 301–309. 10 indexed citations
8.
Sharov, Victor G., Anastassia Todor, George Suzuki, et al.. (2003). Hypoxia, Angiotensin-II, and Norepinephrine Mediated Apoptosis is Stimulus Specific in Canine Failed Cardiomyocytes: A Role for p38 MAPK, Fas-L and Cyclin D1. European Journal of Heart Failure. 5(2). 121–129. 45 indexed citations
9.
Sabbah, Hani N., Victor G. Sharov, Ramesh C. Gupta, et al.. (2003). Reversal of Chronic Molecular and Cellular Abnormalities Due to Heart Failure by Passive Mechanical Ventricular Containment. Circulation Research. 93(11). 1095–1101. 82 indexed citations
10.
Sharov, Victor G., Anastassia Todor, Sidney Goldstein, & Hani N. Sabbah. (2002). Exposure of normal adult cadiomyocytes to active caspase-8 triggers the release of cytochrome C from mitochondria suppresses mitochondrial respiration. Journal of the American College of Cardiology. 39. 176–176. 1 indexed citations
11.
Todor, Anastassia, Victor G. Sharov, George Suzuki, et al.. (2002). Chronic therapy with metoprolol CR/XL prevents apoptosis inducing factor and downregulates the proapoptotic protein Bak in cardiomyocytes of dogs with heart failure. Journal of the American College of Cardiology. 39. 165–165. 2 indexed citations
12.
Mishima, Takayuki, Mitsuhiro Tanimura, George Suzuki, et al.. (2002). Effects of Chronic Neutral Endopeptidase Inhibition on the Progression of Left Ventricular Dysfunction and Remodeling in Dogs with Moderate Heart Failure. Cardiovascular Drugs and Therapy. 16(3). 209–214. 8 indexed citations
13.
Todor, Anastassia, Victor G. Sharov, Elaine J. Tanhehco, et al.. (2002). Hypoxia-induced cleavage of caspase-3 and DFF45/ICAD in human failed cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 283(3). H990–H995. 28 indexed citations
14.
Suzuki, George, Hideaki Morita, Takayuki Mishima, et al.. (2002). Effects of Long-Term Monotherapy With Eplerenone, a Novel Aldosterone Blocker, on Progression of Left Ventricular Dysfunction and Remodeling in Dogs With Heart Failure. Circulation. 106(23). 2967–2972. 154 indexed citations
15.
Sabbah, Hani N., Victor G. Sharov, Pervaiz A. Chaudhry, et al.. (2001). Chronic therapy with the acorn cardiac support device in dogs with chronic heart failure: three and six months hemodynamic, histologic and ultrastructural findings. The Journal of Heart and Lung Transplantation. 20(2). 189–189. 16 indexed citations
16.
Mishima, Takayuki, Mitsuhiro Tanimura, George Suzuki, et al.. (2000). Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure. Journal of the American College of Cardiology. 35(1). 222–229. 36 indexed citations
17.
Sabbah, Hani N., et al.. (2000). Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure. Journal of the American College of Cardiology. 36(5). 1698–1705. 81 indexed citations
18.
Sharov, Victor G., Anastassia Todor, Norman A. Silverman, Sidney Goldstein, & Hani N. Sabbah. (2000). Abnormal Mitochondrial Respiration in Failed Human Myocardium. Journal of Molecular and Cellular Cardiology. 32(12). 2361–2367. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elza D. van Deel Breakdown of academic impact, for papers by Pericle Di Napoli Breakdown of academic impact, for papers by Zhenhong Fu Breakdown of academic impact, for papers by Youchun Jiang Breakdown of academic impact, for papers by Janice M. Pfeffer Breakdown of academic impact, for papers by Suneet Purohit Breakdown of academic impact, for papers by Omar Nass Breakdown of academic impact, for papers by Eduardo M. Escudero Breakdown of academic impact, for papers by Makoto Ariyoshi Breakdown of academic impact, for papers by Quan He
Rankless by CCL
2026